Illumina, a San Diego-based provider of sequencing and array-based technologies, has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of laboratory information management systems (LIMS) for life sciences organizations. The acquisition strengthens Illumina’s portfolio of genetic analysis solutions.
“The acquisition of GenoLogics demonstrates Illumina’s commitment to drive the adoption of sequencing in new markets and improve the genomic information workflow,” said Francis deSouza, president of Illumina.
Adopted by more than 120 genomic labs worldwide, GenoLogics’ Clarity LIMS software enables lab efficiencies and improved sample throughput with increased accuracy, fast turnaround, sample traceability and preconfigured instrument integrations. GenoLogics has a number of current partnerships with Illumina, including the recently launched Clarity LIMS X, an edition of its laboratory informatics platform that is optimized for use with Illumina SeqLab to address population-scale genomics workflows.
GenoLogics will become part of the Illumina Enterprise Informatics business under the leadership of Sanjay Chikarmane, senior vice president and general Manager of Enterprise Informatics.
The acquisition is expected to close by the end of August.